Ajanta Pharma rose 3.16% to Rs 1094 at 9:55 IST on BSE, with the stock extending Monday's 8.46% rally triggered by the company reporting strong Q4 earnings.
Meanwhile, the S&P BSE Sensex was up 123.56 points or 0.55% at 22,568.68.
On BSE, so far 44,000 shares were traded in the counter as against average daily volume of 56,000 shares in the past two weeks.
The stock hit a high of Rs 1115.05 and a low of Rs 1070.55 so far during the day. The stock had hit a record high of Rs 1,138.60 on Monday, 5 May 2014. The stock had hit a 52-week low of Rs 475.34 on 28 August 2013.
Shares of Ajanta Pharma have surged 11.9% in two trading sessions from a recent low of Rs 977.65 on 2 May 2014, after the company during trading hours on Monday, 5 May 2014, reported strong Q4 March 2014 earnings. The stock had rallied 8.46% to settle at Rs 1,060.45 on Monday, 5 May 2014.
Ajanta Pharma's profit after tax (PAT) jumped 159% to Rs 70 crore on 25% growth in revenue from operations to Rs 311 crore in Q4 March 2014 over Q4 March 2013.
Ajanta Pharma's EBITDA (earnings before interest, taxation, depreciation and amortization) surged 63% to Rs 112 crore in Q4 March 2014 over Q4 March 2013.
Exports contributed 66% of the total operating income in Q4 March 2014, Ajanta Pharma said.
Ajanta Pharma's PAT surged 118% to Rs 221 crore on 32% growth in revenue from operations to Rs 1110 crore in the year ended 31 March 2014 (FY 2014) over the year ended 31 March 2013 (FY 2013).
EBITDA jumped 65% to Rs 346 crore in FY 2014 over FY 2013.
Exports contributed 63% of the total operating income for FY 2014, Ajanta Pharma said.
On consolidated basis, Ajanta Pharma's profit after tax jumped 109% to Rs 234 crore on 30% growth in revenue from operations to Rs 1208 crore in FY 2014 over FY 2013.
EBITDA jumped 64% to Rs 369 crore in FY 2014 over FY 2013.
Ajanta Pharma's board of directors at its meeting held on Monday, 5 May 2014, recommended dividend of Rs 10 per share, subject to approval of shareholders at the ensuing Annual General Meeting to be held in 2014.
Ajanta Pharma - a speciality pharmaceutical formulation company has leading brands in therapeutic segments of ophthalmology, dermatology, cardiology and pain management
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app